Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16715952rdf:typepubmed:Citationlld:pubmed
pubmed-article:16715952lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0149566lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0741968lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0007774lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0428883lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C1947917lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0444706lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C1704970lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C0040399lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:16715952lifeskim:mentionsumls-concept:C1880018lld:lifeskim
pubmed-article:16715952pubmed:issue3lld:pubmed
pubmed-article:16715952pubmed:dateCreated2006-5-23lld:pubmed
pubmed-article:16715952pubmed:abstractTextImpaired cerebrovascular reactivity (CVR) to vasodilating agents is a predictor of the onset and prognosis of ischemic stroke. It is realized that the CVR improves or worsens when measured periodically during the clinical course in medically treated patients with occlusive cerebrovascular disease. In these patients, we investigated the possible relationship between the interval change in CVR and that in systemic blood pressure (BP).lld:pubmed
pubmed-article:16715952pubmed:languageenglld:pubmed
pubmed-article:16715952pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16715952pubmed:citationSubsetIMlld:pubmed
pubmed-article:16715952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16715952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16715952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16715952pubmed:statusMEDLINElld:pubmed
pubmed-article:16715952pubmed:monthAprlld:pubmed
pubmed-article:16715952pubmed:issn0914-7187lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:KitagawaKazuo...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:HoriMasatsugu...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:TakasawaMasas...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:HatazawaJunJlld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:OkuNaohikoNlld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:ImaizumiMasao...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:KimuraYasuyuk...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:KajimotoKatsu...lld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:KatohHirokiHlld:pubmed
pubmed-article:16715952pubmed:authorpubmed-author:TanakaMakiko...lld:pubmed
pubmed-article:16715952pubmed:issnTypePrintlld:pubmed
pubmed-article:16715952pubmed:volume20lld:pubmed
pubmed-article:16715952pubmed:ownerNLMlld:pubmed
pubmed-article:16715952pubmed:authorsCompleteYlld:pubmed
pubmed-article:16715952pubmed:pagination209-15lld:pubmed
pubmed-article:16715952pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:meshHeadingpubmed-meshheading:16715952...lld:pubmed
pubmed-article:16715952pubmed:year2006lld:pubmed
pubmed-article:16715952pubmed:articleTitleDiastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.lld:pubmed
pubmed-article:16715952pubmed:affiliationDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, D9, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.lld:pubmed
pubmed-article:16715952pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16715952pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16715952pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed